abiraterone accord
accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone medac 250 mg tablett
medac gesellschaft für klinische spezialpräparate mbh - abirateronacetat - tablett - 250 mg - abirateronacetat 250 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne
abiraterone stada 500 mg filmdragerad tablett
stada arzneimittel ag - abirateronacetat - filmdragerad tablett - 500 mg - abirateronacetat 500 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne
abiraterone qilu 500 mg filmdragerad tablett
qilu pharma spain s.l. - abirateronacetat - filmdragerad tablett - 500 mg - abirateronacetat 500 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne
abirateron aristo 500 mg filmdragerad tablett
aristo pharma gmbh - abirateronacetat - filmdragerad tablett - 500 mg - abirateronacetat 500 mg aktiv substans; laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne
abiraterone fresenius kabi 250 mg tablett
fresenius kabi ab - abirateronacetat - tablett - 250 mg - laktosmonohydrat hjälpämne; abirateronacetat 250 mg aktiv substans; natriumlaurilsulfat hjälpämne
abiraterone fresenius kabi 500 mg filmdragerad tablett
fresenius kabi ab - abirateronacetat - filmdragerad tablett - 500 mg - laktosmonohydrat hjälpämne; abirateronacetat 500 mg aktiv substans; natriumlaurilsulfat hjälpämne
abiraterone medac 500 mg filmdragerad tablett
medac gesellschaft für klinische spezialpräparate mbh - abirateronacetat - filmdragerad tablett - 500 mg - laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; abirateronacetat 500 mg aktiv substans